Amelioration of lipopolysaccharide-induced sepsis in rats by free and esterified carnitine
1993

Carnitine and Sepsis in Rats

Sample size: 17 publication Evidence: moderate

Author Information

Author(s): Linda L. Gallo, Yan Tian, Zaven Orfalian, Gary Fiskum

Primary Institution: The George Washington University Medical Center

Hypothesis

Carnitine and/or novel carnitine esters may be effective in normalizing lipid metabolism in sepsis and endotoxaemia.

Conclusion

Carnitine treatment significantly reduced illness and improved recovery in LPS-treated rats.

Supporting Evidence

  • Carnitine administration prevented the rise in serum triglycerides in LPS-treated rats.
  • Health status improved significantly in carnitine-treated groups compared to LPS controls.
  • Food consumption was higher in carnitine groups than in LPS-only groups.
  • Liver lipogenesis was significantly reduced in carnitine-treated rats.
  • Total liver carnitine levels were significantly higher in carnitine-treated groups.

Takeaway

This study found that giving carnitine to sick rats helped them feel better and recover faster from an illness caused by bacteria.

Methodology

Male Sprague Dawley rats were treated with LPS and administered carnitine or VBT carnitine, with health and survival monitored over 96 hours.

Limitations

The study was conducted on rats, which may not fully represent human responses.

Participant Demographics

Male Sprague Dawley rats weighing 250-300 g.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication